Dalton Pharma News

News & Events

Welcome to Dalton Pharma Services News and Events.

On this page you will find our current and past news releases and a list of event happenings. If you can't find what you are looking for, please contact us and we will be happy to provide you with assistance.

9/10/2018 17:35 Dalton increases its sterile fill/finish capabilities by adding a State-of-the-Art, fully automated fill line

As a part of a 10 million dollar facility and capital expansion, Dalton Pharma Services, a leading North American contract research, development & manufacturing organization has invested in a fully automated Sterile Liquid Filling System that will become operational in Q1 of 2019.

8/14/2018 00:00 Arch Biopartners Engages Dalton Pharma Services for GMP Manufacturing of Metablok

Arch Biopartners, Inc., today announced it has engaged Dalton Pharma Services to perform the good manufacturing practice (GMP) campaign for Metablok, (LSALT peptide), the Company's drug candidate for preventing acute kidney injury.

7/19/2018 00:00 DALTON adds state-of-the-art ICP-MS Capability

Dalton expands its elemental analysis testing capabilities with the addition of an ICP-MS System.

6/6/2018 00:00 Dalton Pharma Services Receives Compliant Rating from Health Canada

Dalton received a Compliant rating from Health Canada following a successful GMP inspection of its manufacturing facility in March, 2018.

5/10/2018 00:00 DALTON Named One of the Top 50 Companies to Work for in Canada

Canada's leading pharmaceutical CMO, Dalton Pharma Services, is recognized as a Best Workplace™ in Canada, 2018

4/26/2018 00:00 Dalton Pharma Services Wins 2018 CMO Leadership Awards

For the third year in a row, Dalton Pharma Services, has won the Life Sciences Leader- CMO Leadership Award in 2018.

3/15/2018 00:00 Dalton Announces a Drug Development and GMP Manufacturing Services Agreement with Oryn Therapeutics

Dalton Announces a Drug Development and GMP Manufacturing Services Agreement with Oryn Therapeutics

10/21/2017 09:00 Dalton Pharma Services Officially Re-certified as a Great Place to Work

Dalton Pharma Services, has been re-certified for a second consecutive year in 2017 as one of the Best Canadian Companies to work for, by a global research and consulting firm Great Place to Work®.

5/9/2017 15:50 Dalton Announces a Drug Development and GMP Manufacturing Services Agreement with Arch Biopartners

Dalton Pharma Services, a leading pharmaceutical cGMP contract manufacturing company, today announced the signing of a drug development and manufacturing services agreement with Arch Biopartners, Inc., a Canadian biotechnology firm focused on the development of technologies that have the potential to make a significant medical or commercial impact.

3/9/2017 09:00 An Interview With Peter Pekos, President & CEO, Dalton Pharma Services

Pharmaceutical Outsourcing conducts an interview with Peter Pekos, President & CEO, Dalton Pharma Services.